ArticleCureus2021
Unveiling Uncommon Manifestations in a Pediatric Patient With Systemic Lupus Erythematosus: A Case Report.
Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- [Oral pathologies in pediatric patients related to juvenile systemic lupus erythematosus and considerations in stomatological management. A review].Revista cientifica odontologica (Universidad Cientifica del Sur)Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with multi-organ involvement. It may involve skin, kidneys, joints, central nervous system (CNS), and cardiopulmonary system. Marked variations in clinical presentations are seen in SLE patients, ranging from subclinical to life-threatening manifestations. SLE and antiphospholipid syndrome (APS) may be associated with Libman-Sacks endocarditis. Visceral vasculitis usually manifests with disease flares and can affect almost any organ. APS can have arterial or venous thrombosis and the presence of persistently positive antiphospholipid antibodies (aPL), including lupus anticoagulants (LA), anticardiolipin antibodies (aCL), and/or anti-β2-glycoprotein-I antibodies (aβ2GPI). Peripheral neuropathy is unusual in pediatric patients. We present a case of an adolescent girl with juvenile SLE (JSLE) in whom endocarditis and digital gangrene at first presentation were actually masquerading underlying life-threatening secondary APS with extensive medium vessel thrombosis. Additionally, there was cutaneous and visceral vasculitis and a rare peripheral nervous system (PNS) manifestation, mononeuritis multiplex (MNM).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.